Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer - PubMed
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
E E Cameron et al. Nat Genet. 1999 Jan.
Abstract
Densely methylated DNA associates with transcriptionally repressive chromatin characterized by the presence of underacetylated histones. Recently, these two epigenetic processes have been dynamically linked. The methyl-CpG-binding protein MeCP2 appears to reside in a complex with histone deacetylase activity. MeCP2 can mediate formation of transcriptionally repressive chromatin on methylated promoter templates in vitro, and this process can be reversed by trichostatin A (TSA), a specific inhibitor of histone deacetylase. Little is known, however, about the relative roles of methylation and histone deacetylase activity in the stable inhibition of transcription on densely methylated endogenous promoters, such as those for silenced alleles of imprinted genes, genes on the female inactive X chromosome and tumour-suppressor genes inactivated in cancer cells. We show here that the hypermethylated genes MLH1, TIMP3 (TIMP3), CDKN2B (INK4B, p15) and CDKN2A (INK4, p16) cannot be transcriptionally reactivated with TSA alone in tumour cells in which we have shown that TSA alone can upregulate the expression of non-methylated genes. Following minimal demethylation and slight gene reactivation in the presence of low dose 5-aza-2'deoxycytidine (5Aza-dC), however, TSA treatment results in robust re-expression of each gene. TSA does not contribute to demethylation of the genes, and none of the treatments alter the chromatin structure associated with the hypermethylated promoters. Thus, although DNA methylation and histone deacetylation appear to act as synergistic layers for the silencing of genes in cancer, dense CpG island methylation is dominant for the stable maintenance of a silent state at these loci.
Similar articles
-
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
Kondo Y, Shen L, Issa JP. Kondo Y, et al. Mol Cell Biol. 2003 Jan;23(1):206-15. doi: 10.1128/MCB.23.1.206-215.2003. Mol Cell Biol. 2003. PMID: 12482974 Free PMC article.
-
Meng CF, Su B, Li W. Meng CF, et al. Mol Med Rep. 2011 Nov-Dec;4(6):1273-8. doi: 10.3892/mmr.2011.557. Epub 2011 Aug 16. Mol Med Rep. 2011. PMID: 21850374
-
Magdinier F, Wolffe AP. Magdinier F, et al. Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4990-5. doi: 10.1073/pnas.101617298. Epub 2001 Apr 17. Proc Natl Acad Sci U S A. 2001. PMID: 11309512 Free PMC article.
-
Gene methylation in gastric cancer.
Qu Y, Dang S, Hou P. Qu Y, et al. Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review.
-
DNA methylation changes and multiple myeloma.
Ng MH, Wong IH, Lo KW. Ng MH, et al. Leuk Lymphoma. 1999 Aug;34(5-6):463-72. doi: 10.3109/10428199909058473. Leuk Lymphoma. 1999. PMID: 10492069 Review.
Cited by
-
Yves P, Stephane M, Rishika B, Christine D, Gérard P. Yves P, et al. Leuk Res Treatment. 2015;2015:476805. doi: 10.1155/2015/476805. Epub 2015 Jun 14. Leuk Res Treatment. 2015. PMID: 26199759 Free PMC article.
-
Liang Q, Xu Z, Xu R, Wu L, Zheng S. Liang Q, et al. PLoS One. 2012;7(1):e29950. doi: 10.1371/journal.pone.0029950. Epub 2012 Jan 6. PLoS One. 2012. PMID: 22238681 Free PMC article.
-
Effects of 5-aza-2´-deoxycytidine on primary human chondrocytes from osteoarthritic patients.
Kadler S, Vural Ö, Rosowski J, Reiners-Schramm L, Lauster R, Rosowski M. Kadler S, et al. PLoS One. 2020 Jun 23;15(6):e0234641. doi: 10.1371/journal.pone.0234641. eCollection 2020. PLoS One. 2020. PMID: 32574164 Free PMC article.
-
The pituitary tumour epigenome: aberrations and prospects for targeted therapy.
Yacqub-Usman K, Richardson A, Duong CV, Clayton RN, Farrell WE. Yacqub-Usman K, et al. Nat Rev Endocrinol. 2012 Apr 24;8(8):486-94. doi: 10.1038/nrendo.2012.54. Nat Rev Endocrinol. 2012. PMID: 22525730 Review.
-
Drugging the undruggable: transcription therapy for cancer.
Yan C, Higgins PJ. Yan C, et al. Biochim Biophys Acta. 2013 Jan;1835(1):76-85. doi: 10.1016/j.bbcan.2012.11.002. Epub 2012 Nov 9. Biochim Biophys Acta. 2013. PMID: 23147197 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous